AXLA / Axcella Health Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

阿克塞拉健康公司
US ˙ OTCPK ˙ US05454B1052
該符號不再有效

內部人士股份1,125,152 shares
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

N/A

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

N/A

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Axcella Health Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 AXLA / Axcella Health Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2022-10-13 Societe des Produits Nestle S.A. 3,658,536 1.6400 146,341 41.0000 5,999,999 1 44.75 548,761 9.15
2022-10-13 Flagship Ventures Fund IV General Partner LLC 2,743,902 1.6400 109,756 41.0000 4,499,999
2022-10-13 Flagship Ventures Fund IV General Partner LLC 2,757,333 1.6400 110,293 41.0000 4,522,026
2022-10-13 Flagship Ventures Fund IV General Partner LLC 914,634 1.6400 36,585 41.0000 1,500,000
2022-10-13 Flagship Ventures Fund IV General Partner LLC 919,111 1.6400 36,764 41.0000 1,507,342
2022-10-13 Flagship Ventures Fund IV General Partner LLC 3,048,780 1.6400 121,951 41.0000 4,999,999
2022-03-16 Flagship Ventures Fund IV General Partner LLC 3,791,623 1.9100 151,665 47.7500 7,242,000
2022-03-16 Flagship Ventures Fund IV General Partner LLC 947,905 1.9100 37,916 47.7500 1,810,499
2022-03-16 Flagship Ventures Fund IV General Partner LLC 1,579,843 1.9100 63,194 47.7500 3,017,500

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

AXLA / Axcella Health Inc. Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 AXLA / Axcella Health Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2022-10-19 Hinshaw William 16,000 1.5642 640 39.1050 25,027 77 0.3057 -24,831 -99.22
2022-09-06 Koziel Margaret 547 2.5195 22 62.9875 1,378
2022-06-01 Koziel Margaret 590 2.0107 24 50.2675 1,186
2022-03-01 Koziel Margaret 553 1.8618 22 46.5450 1,030
2022-01-31 Hinshaw William 16,590 1.6512 664 41.2800 27,393
2021-02-01 Chakravarthy Manu 18,472 5.5019 739 137.5475 101,631

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

AXLA / Axcella Health Inc. Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2023-03-03 2023-03-01 4 Koziel Margaret AXLA Common Stock S - Sale D 0.5800 -679 -0 24,883
2023-02-13 2023-02-10 4 Fehlner Paul AXLA Common Stock S - Sale D 0.6602 5,221 3 58,081
2022-10-19 2022-10-19 4 Hinshaw William AXLA Common Stock S - Sale D 1.5642 -16,000 -25 82,012
2022-10-19 2022-10-17 4 Hinshaw William AXLA Common Stock A - Award D 50,000 98,012
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By FPA, L.P. AXLA Common Stock P - Purchase I 1.6400 3,048,780 5,000 3,048,780
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1.6400 919,111 1,507 6,299,611
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1.6400 914,634 1,500 5,380,500
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1.6400 2,757,333 4,522 14,101,638
2022-10-17 2022-10-13 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1.6400 2,743,902 4,500 11,344,305
2022-10-17 3 FPA, L.P. By FPA, L.P. AXLA Common Stock I 3,048,780
2022-10-17 2022-10-13 4 Societe des Produits Nestle S.A. AXLA Common Stock P - Purchase I 1.6400 3,658,536 6,000 11,105,438
2022-09-08 2022-09-06 4 Koziel Margaret AXLA Common Stock S - Sale D 2.5195 -547 -1 25,562
2022-06-03 2022-05-19 4 Epstein David R AXLA Common Stock A - Award D 47,059 209,756
2022-06-02 2022-06-01 4 Koziel Margaret AXLA Common Stock S - Sale D 2.0107 -590 -1 26,109
2022-05-25 2022-05-19 4 SEKHRI PAUL J AXLA Stock Option (Right to Buy) A - Award D 1.70 40,000 40,000
2022-05-23 2022-05-19 4 Hendrix Martin AXLA Stock Option (Right to Buy) A - Award D 1.70 40,000 40,000
2022-05-23 2022-05-19 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 1.70 20,000 20,000
2022-05-23 2022-05-19 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 1.70 20,000 20,000
2022-05-23 2022-05-19 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 1.70 20,000 20,000
2022-05-23 2022-05-19 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 1.70 20,000 20,000
2022-05-23 3 Rosenblatt Michael AXLA Common Stock D 3,053
2022-05-23 2022-05-19 4 Rosenblatt Michael AXLA Stock Option (Right to Buy) A - Award D 1.70 40,000 40,000
2022-03-21 2022-03-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 0
2022-03-21 2022-03-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 162,697
2022-03-21 2022-03-17 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 2.51 50,000 50,000
2022-03-18 2022-03-16 4 Crane Robert AXLA Stock Option (Right to Buy) A - Award D 1.63 125,000 125,000
2022-03-18 2022-03-16 4 Hinshaw William AXLA Common Stock P - Purchase D 1.9100 13,089 25 48,012
2022-03-18 2022-03-16 4 Crane Robert AXLA Common Stock P - Purchase D 1.9100 39,267 75 39,267
2022-03-18 2022-03-16 4 Epstein David R AXLA Common Stock P - Purchase D 1.9100 26,178 50 161,162
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Opportunities I, L.P. AXLA Common Stock P - Purchase I 1.9100 1,579,843 3,018 4,465,866
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV-Rx, L.P. AXLA Common Stock P - Purchase I 1.9100 947,905 1,810 2,004,657
2022-03-18 2022-03-16 4 Flagship Ventures Fund IV General Partner LLC By Flagship Ventures Fund IV, L.P. AXLA Common Stock P - Purchase I 1.9100 3,791,623 7,242 8,600,403
2022-03-18 2022-03-16 4 Fehlner Paul AXLA Common Stock P - Purchase D 1.9100 10,471 20 20,802
2022-03-16 2022-03-16 4 Societe des Produits Nestle S.A. AXLA Common Stock P - Purchase I 1.9100 3,141,361 6,000 7,446,902
2022-03-03 2022-03-01 4 Koziel Margaret AXLA Common Stock S - Sale D 1.8618 -553 -1 26,699
2022-02-23 2022-02-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,534 1,535
2022-02-23 2022-02-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,534 134,984
2022-02-10 2022-02-08 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 1.63 56,000 56,000
2022-02-10 2022-02-08 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 1.63 70,000 70,000
2022-02-10 2022-02-08 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 5.00 100,000 100,000
2022-02-10 2022-02-08 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 1.63 275,000 275,000
2022-02-10 2022-02-08 4 Koziel Margaret AXLA Stock Option (Right to Buy) A - Award D 1.63 33,397 33,397
2022-02-10 2022-02-08 4 Dean Virginia R AXLA Stock Option (Right to Buy) A - Award D 1.63 71,400 71,400
2022-02-01 2022-01-31 4 Hinshaw William AXLA Common Stock S - Sale D 1.6512 -16,590 -27 33,410
2022-02-01 2022-01-28 4 Hinshaw William AXLA Restricted Stock Units M - Exercise D -50,000 0
2022-02-01 2022-01-28 4 Hinshaw William AXLA Common Stock M - Exercise D 50,000 50,000
2022-01-20 2022-01-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 3,069
2022-01-20 2022-01-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 133,450
2021-12-20 2021-12-17 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 4,604
2021-12-20 2021-12-17 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 131,915
2021-12-14 2021-12-10 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 5.57 25,000 25,000
2021-12-13 3 Koziel Margaret AXLA Common Stock D 30,000
2021-12-13 2021-12-10 4 Koziel Margaret AXLA Stock Option (Right to Buy) A - Award D 2.60 75,000 75,000
2021-11-22 2021-11-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,534 6,139
2021-11-22 2021-11-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,534 130,380
2021-10-19 2021-10-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 7,673
2021-10-19 2021-10-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 128,846
2021-09-20 2021-09-17 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 9,208
2021-09-20 2021-09-17 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 127,311
2021-08-25 2021-08-13 4 Pisano Gary P. AXLA Stock Option (Right to Buy) M - Exercise D 0.28 -81,433 0
2021-08-25 2021-08-13 4 Pisano Gary P. AXLA Common Stock M - Exercise D 0.2800 81,433 23 81,433
2021-08-19 2021-08-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,534 10,743
2021-08-19 2021-08-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,534 125,776
2021-07-20 2021-07-16 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 12,277
2021-07-20 2021-07-16 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 124,242
2021-06-25 2021-06-22 4 Dean Virginia R AXLA Stock Option (Right to Buy) A - Award D 4.15 140,000 140,000
2021-06-21 2021-06-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 13,812
2021-06-21 2021-06-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 122,707
2021-05-24 2021-05-20 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-24 2021-05-20 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 3.24 20,000 20,000
2021-05-20 2021-05-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,534 15,347
2021-05-20 2021-05-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,534 121,172
2021-04-20 2021-04-18 4 Epstein David R AXLA Restricted Stock Units M - Exercise D -1,535 16,881
2021-04-20 2021-04-18 4 Epstein David R AXLA Common Stock M - Exercise D 1,535 119,638
2021-03-22 2021-03-18 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 5.43 120,000 120,000
2021-03-22 2021-03-18 4 Epstein David R AXLA Restricted Stock Units A - Award D 18,416 18,416
2021-03-18 2021-03-17 4 Schecter Alison D. AXLA Stock Option (Right to Buy) A - Award D 5.57 250,000 250,000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 3.40 25,000 25,000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 6.59 120,000 120,000
2021-02-11 2021-02-09 4 Chardonnet Laurent AXLA Restricted Stock Units A - Award D 60,000 60,000
2021-02-11 2020-10-30 4 Chardonnet Laurent AXLA Common Stock A - Award D 3.6000 2,601 9 6,266
2021-02-11 2021-02-09 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 6.59 85,000 85,000
2021-02-11 2021-02-09 4 Fehlner Paul AXLA Restricted Stock Units A - Award D 42,500 42,500
2021-02-11 2021-02-09 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 6.59 375,000 375,000
2021-02-11 2021-02-09 4 Chakravarthy Manu AXLA Stock Option (Right to Buy) A - Award D 6.59 102,000 102,000
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Restricted Stock Units M - Exercise D 60,000 60,000
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Common Stock S - Sale D 5.5019 -18,472 -102 41,528
2021-02-03 2021-02-01 4 Chakravarthy Manu AXLA Common Stock M - Exercise D 60,000 60,000
2021-02-03 2020-08-01 4 Chakravarthy Manu AXLA Restricted Stock Units A - Award D 60,000 60,000
2020-10-01 2020-09-29 4 Hinshaw William AXLA Restricted Stock Units A - Award D 50,000 50,000
2020-09-18 2020-09-16 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 4.72 30,000 30,000
2020-09-09 2020-09-08 4 Societe des Produits Nestle S.A. AXLA Common Stock J - Other D 4.4200 4,305,541 19,030 4,305,541
2020-09-03 2020-09-01 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 4.89 22,000 22,000
2020-06-08 2020-06-05 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 9.00 6,800 6,800
2020-05-22 2020-05-20 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-22 2020-05-20 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-22 2020-05-20 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 4.20 65,000 65,000
2020-05-22 2020-05-20 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 4.20 35,000 35,000
2020-05-22 2020-05-20 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-22 2020-05-20 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-22 2020-05-20 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-22 2020-05-20 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 4.20 11,000 11,000
2020-05-21 2020-05-18 4 Nestle Health Science US Holdings, Inc. AXLA Common Stock P - Purchase I 4.7500 1,936,842 9,200 4,305,541
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4.7500 1,900,000 9,025 2,886,023
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4.7500 380,000 1,805 1,056,752
2020-05-20 2020-05-18 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 4.7500 1,520,000 7,220 4,808,780
2020-05-20 2020-05-18 4 Epstein David R AXLA Common Stock P - Purchase D 4.7500 50,000 238 118,103
2020-03-02 2020-02-28 4 Epstein David R AXLA Common Stock P - Purchase D 3.7500 2,005 8 68,103
2020-03-02 2020-02-27 4 Epstein David R AXLA Common Stock P - Purchase D 3.6500 12,800 47 66,098
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-02-14 3 NIMCO US, Inc. AXLA Common Stock I 4,737,398
2020-01-31 2020-01-31 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4.9400 3,000 15 3,665
2020-01-28 2020-01-27 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4.9400 352 2 665
2020-01-28 2020-01-24 4 Chardonnet Laurent AXLA Common Stock P - Purchase D 4.9200 313 2 313
2020-01-21 2020-01-17 4 Sohn Catherine A. AXLA Common Stock P - Purchase D 4.8700 1,000 5 1,000
2020-01-03 2020-01-02 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 4.12 156,700 156,700
2019-12-20 2019-12-18 4 Chardonnet Laurent AXLA Stock Option (Right to Buy) A - Award D 3.40 72,500 72,500
2019-12-20 2019-12-18 4 Chakravarthy Manu AXLA Stock Option (Right to Buy) A - Award D 3.40 41,000 41,000
2019-12-20 2019-12-18 4 Fehlner Paul AXLA Stock Option (Right to Buy) A - Award D 3.40 18,000 18,000
2019-12-20 2019-12-18 4 Aradhye Shreeram AXLA Restricted Stock Units A - Award D 66,801 66,801
2019-12-20 2019-12-18 4 Aradhye Shreeram AXLA Stock Option (Right to Buy) A - Award D 3.40 54,500 54,500
2019-12-20 2019-12-18 4 Tramontin Tony AXLA Stock Option (Right to Buy) A - Award D 3.40 45,000 45,000
2019-12-20 2019-12-18 4 King-Jones Heidy AXLA Stock Option (Right to Buy) A - Award D 3.40 35,000 35,000
2019-12-20 2019-12-18 4 Mitchener Stephen AXLA Stock Option (Right to Buy) A - Award D 3.40 43,000 43,000
2019-12-03 2019-11-27 4 Epstein David R AXLA Common Stock P - Purchase D 3.9100 1,005 4 53,298
2019-12-03 2019-11-26 4 Epstein David R AXLA Common Stock P - Purchase D 3.5500 14,000 50 52,293
2019-12-02 2019-11-27 4 Epstein David R AXLA Common Stock P - Purchase D 3.9100 1,005 4 53,298
2019-12-02 2019-11-26 4 Epstein David R AXLA Common Stock P - Purchase D 3.5500 14,000 50 52,293
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8,142
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8,142
2019-08-29 3 Maltbie Shane AXLA Common Stock D 8,142
2019-08-23 2019-08-21 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 8.11 65,000 65,000
2019-08-23 2019-08-21 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 8.11 35,000 35,000
2019-08-23 2019-08-21 4 Sohn Catherine A. AXLA Stock Option (Right to Buy) A - Award D 8.11 22,000 22,000
2019-08-05 2019-08-02 4 Epstein David R AXLA Common Stock P - Purchase D 7.0400 2,849 20 38,293
2019-08-05 2019-08-01 4 Epstein David R AXLA Common Stock P - Purchase D 6.9800 4,092 29 35,444
2019-07-18 2019-07-17 4 Epstein David R AXLA Common Stock P - Purchase D 7.5500 1,000 8 31,352
2019-07-10 2019-07-10 4 Epstein David R AXLA Common Stock P - Purchase D 8.0700 1,322 11 30,352
2019-07-10 2019-07-09 4 Epstein David R AXLA Common Stock P - Purchase D 8.2400 4,200 35 29,030
2019-07-10 2019-07-08 4 Epstein David R AXLA Common Stock P - Purchase D 9.0000 274 2 24,830
2019-07-03 2019-07-03 4 Epstein David R AXLA Common Stock P - Purchase D 8.9900 56 1 19,056
2019-07-03 2019-07-02 4 Epstein David R AXLA Common Stock P - Purchase D 8.7650 3,500 31 19,000
2019-07-03 2019-07-01 4 Epstein David R AXLA Common Stock P - Purchase D 8.7350 1,000 9 15,500
2019-07-01 2019-06-28 4 Epstein David R AXLA Common Stock P - Purchase D 10.0400 5,400 54 20,000
2019-07-01 2019-06-27 4 Epstein David R AXLA Common Stock P - Purchase D 9.1500 100 1 14,600
2019-06-27 2019-06-26 4 Epstein David R AXLA Common Stock P - Purchase D 9.5700 14,500 139 14,500
2019-05-24 2019-05-22 4 Epstein David R AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Hinshaw William AXLA Stock Option (Right to Buy) A - Award D 13.83 60,803 60,803
2019-05-24 2019-05-22 4 BERRY DAVID A AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Pisano Gary P. AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Hoge Stephen AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Rondinone CRISTINA AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Baird William D III AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-24 2019-05-22 4 Behar Gregory AXLA Stock Option (Right to Buy) A - Award D 14.28 11,000 11,000
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -895,255 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -89,525 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series E Preferred Stock C - Conversion I -358,102 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -151,643 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -617,914 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series C Preferred Stock C - Conversion I -222,506 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -1,005,413 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -928,074 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series B Preferred Stock C - Conversion I -386,697 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series A Preferred Stock C - Conversion I -4,153,847 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Series A Preferred Stock C - Conversion I -1,384,615 0
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock P - Purchase I 20.0000 500,000 10,000 986,023
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 486,023 486,023
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 48,602 676,752
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 194,409 3,288,780
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 82,324 628,150
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 335,457 3,094,371
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 120,795 1,761,029
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 545,826 545,826
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 503,840 2,758,914
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 209,933 1,640,234
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 2,255,074 2,255,074
2019-05-15 2019-05-13 4 Flagship Ventures Fund IV General Partner LLC AXLA Common Stock C - Conversion I 751,691 1,430,301
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1,520,084
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1,520,084
2019-05-08 3 BERRY DAVID A AXLA Common Stock D 1,520,084
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 3,393,050
2019-05-08 3 KANIA EDWIN M JR AXLA Common Stock I 4,750,270
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista